Two-stage hepatectomy for multiple bilobar colorectal liver metastases

British Journal of Surgery

Volumn 98, Issue 10, 2011, Pages 1463-1475

  Narita, M ^a   Oussoultzoglou, E ^a   Jaeck, D ^a   Fuchschuber, P ^b   Rosso, E ^a   Pessaux, P ^a   Marzano, E ^a   Bachellier, P ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL PROTOCOL; COLORECTAL TUMOR; EVALUATION; FEMALE; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PEROPERATIVE CARE; PORTAL VEIN; TREATMENT OUTCOME;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; CLINICAL PROTOCOLS; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; TREATMENT OUTCOME;

EID: 80052414471     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7580     Document Type: Article

References (48)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al., Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
2. Leonard GD, Brenner B, Kemeny NE,. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23: 2038-2048.
3. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, et al., Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie. Br J Surg 1997; 84: 977-980.
4. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al., Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825.
5. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al., Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-722.
6. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG,. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
7. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al., Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial. J Clin Oncol 2006; 24: 3347-3353.
8. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al., Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
9. Van Cutsem E, Köhne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, et al., Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009; 360: 1408-1417.
10. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al., Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240: 644-657.
11. Folprecht G, Grothey A, Alberts S, Raab HR, Köhne CH,. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16: 1311-1319.
12. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H,. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232: 777-785.
13. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P,. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037-1049.
14. Adam R,. Developing strategies for liver metastases from colorectal cancer. Semin Oncol 2007; 34: S7-S11.
15. Abdalla EK, Hicks ME, Vauthey JN,. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88: 165-175.
16. Szijártó A, Hargitai B, Fischer S, Darvas K, Kupcsulik P,. Two-staged procedure of portal ligation and hepatectomy monitored by ICG clearance. J Invest Surg 2009; 22: 63-68.
17. Oussoultzoglou E, Bachellier P, Rosso E, Scurtu R, Lucescu I, Greget M, et al., Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg 2006; 244: 71-79.
18. Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D,. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery 2008; 143: 476-482.
19. Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P,. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86: 784-788.
20. Oussoultzoglou E, Romain B, Panaro F, Rosso E, Pessaux P, Bachellier P, et al., Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens. Ann Surg 2009; 249: 879-886.
21. Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, et al., Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008; 12: 297-303.
22. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
23. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al., The '50-50 criteria' on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242: 824-848.
24. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al., Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204: 854-862.
25. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
26. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, et al., Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 2008; 248: 994-1005.
27. Tanaka K, Shimada H, Matsuo K, Ueda M, Endo I, Togo S,. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 2007; 33: 329-335.
28. Homayounfar K, Liersch T, Schuetze G, Niessner M, Goralczyk A, Meller J, et al., Two-stage hepatectomy (R0) with portal vein ligation-towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis 2009; 24: 409-418.
29. Karoui M, Vigano L, Goyer P, Ferrero A, Luciani A, Aglietta M, et al., Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg 2010; 97: 1354-1362.
30. Beal IK, Anthony S, Papadopoulou A, Hutchins R, Fusai G, Begent R, et al., Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol 2006; 79: 473-478.
31. Goéré D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J,. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 2006; 10: 365-370.
32. Mentha G, Terraz S, Morel P, Andres A, Giostra E, Roth A, et al., Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases. Br J Surg 2009; 96: 95-103.
33. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al.,; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016.
34. Zacharias T, Jaeck D, Oussoultzoglou E, Bachellier P, Weber JC,. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg 2004; 240: 858-865.
35. Shaw IM, Rees M, Welsh FK, Bygrave S, John TG,. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg 2006; 93: 457-464.
36. Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Togo S,. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol 2007; 14: 1336-1346.
37. Togo S, Nagano Y, Masui H, Tanaka K, Miura Y, Morioka D, et al., Two-stage hepatectomy for multiple bilobular liver metastases from colorectal cancer. Hepatogastroenterology 2005; 52: 913-919.
38. Pamecha V, Nedjat-Shokouhi B, Gurusamy K, Glantzounis GK, Sharma D, Davidson BR,. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig Surg 2008; 25: 387-393.
39. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, et al., Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 2007; 11: 1498-1504.
40. Uesaka K, Nimura Y, Nagino M,. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1996; 223: 77-83.
41. Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR,. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer 2009; 100: 617-622.
42. Hayashi S, Baba Y, Ueno K, Nakajo M, Kubo F, Ueno S, et al., Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol 2007; 48: 721-727.
43. Barbaro B, Di Stasi C, Nuzzo G, Vellone M, Giuliante F, Marano P,. Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol 2003; 44: 98-102.
44. Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VH, Groom AC, et al., Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat 2003; 82: 199-206.
45. Aguirre-Ghiso JA,. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007; 7: 834-846.
46. Naumov GN, Akslen LA, Folkman J,. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 2006; 5: 1779-1787.
47. Yokoyama Y, Nagino M, Nimura Y,. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 2007; 31: 367-374.
48. Bockhorn M, Goralski M, Prokofiev D, Dammann P, Grunewald P, Trippler M, et al., VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res 2007; 138: 291-299.